"Empire Clinical Research is a dedicated research site conveniently located off Garey Avenue, in Pomona, California. We specialize in conducting Phase II-IV clinical studies for pharmaceutical companies seeking FDA approval for new drugs, vaccines and medical devices. We have extensive experience working with many of the largest pharmaceutical companies in the industry. Empire is determined to offer the best studies to their patients and all studies offer compensation for participants. We are committed to elevating the perception and quality of research through communication with the pharmaceutical industry, the community, and our patients."

During the past decade, Empire Clinical Research conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 17 clinical trials were completed, i.e. on average, 54.8% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 12 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Empire Clinical Research" #1 sponsor was "Pfizer" with 6 trials, followed by "Idorsia Pharmaceuticals Ltd." with 3 trials sponsored, "ModernaTX, Inc." with 2 trials sponsored, "Zosano Pharma Corporation" with 2 trials sponsored and "Adiga Life Sciences, Inc." with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Empire Clinical Research" #1 collaborator was "ACM" with 1 trials as a collaborator, "Accelovance" with 1 trials as a collaborator, "Circassia Limited" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Empire Clinical Research" are "Diabetes Mellitus, Type 2" (2 trials), "Influenza, Human" (2 trials), "Insomnia Disorder" (2 trials), "Acne Vulgaris" (1 trials) and "Acute Migraine" (1 trials). Many other conditions were trialed in "Empire Clinical Research" in a lesser frequency.

Most popular intervention types in "Empire Clinical Research" are "Drug" (27 trials), "Biological" (5 trials), "Other" (5 trials), "Combination Product" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "AD109" (1 trials), "Abrocitinib 200 mg" (1 trials), "Afluria® Quadrivalent" (1 trials) and "Amantadine, Ribavirin, Oseltamivir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Empire Clinical Research" are 29 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Empire Clinical Research". undefined are not yet recruiting, undefined are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Empire Clinical Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Empire Clinical Research, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".